TACE combined with sorafenib induces complete remission in an elderly patient with hepatocellular carcinoma, hepatic venous tumor thrombus, and diffuse lung metastasis: a case study and literature review
Open Access
- 7 January 2026
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1693092
Abstract
Hepatocellular carcinoma (HCC) with hepatic venous tumor thrombus (HVTT) and synchronous lung metastases has a poor prognosis and limited treatment options. We present a 70-year-old male with chronic hepatitis B and BCLC stage C HCC, featuring a large liver tumor (14×12×10 cm), HVTT, and diffuse lung metastases. The patient was treated with transarterial gene embolization (TAGE) using gelatin sponge microparticles and rAd-p53 (Gendicine ® ), followed by sorafenib. Imaging showed rapid tumor necrosis at 4 days, significant reduction of lung nodules at 4 weeks, and complete tumor necrosis with resolution of lung metastases at 15 weeks. The patient achieved complete remission and remains alive with 14-year survival.Keywords
This publication has 26 references indexed in Scilit:
- PD1+ Treg cell remodeling promotes immune homeostasis within peripheral blood and tumor microenvironment after microparticles-transarterial chemoembolization in hepatocellular carcinomaCancer Immunology, Immunotherapy, 2025
- Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafenib responsive to post-embolization microenvironmentJournal of Controlled Release, 2025
- The past, present, and future of liver cancer research in ChinaCancer Letters, 2023
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- Variation of NK, NKT, CD4+ T, CD8+ T cells, and IL-17A by CalliSpheres® microspheres-transarterial chemoembolization in refractory liver metastases patientsScandinavian Journal of Clinical and Laboratory Investigation, 2022
- New concepts in the treatment of hepatocellular carcinomaUnited European Gastroenterology Journal, 2022
- Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective studyExpert Review of Gastroenterology & Hepatology, 2022
- 350–560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinomaMedicine, 2017
- Trans-arterial p53-Gene-Embolization with Gelatin Sponge Microparticles for Hepatocellular Carcinoma with BCLC Stage B: Single-Center ExperienceCell Biochemistry and Biophysics, 2014
- Report of the 15th follow-up survey of primary liver cancerHepatology Research, 2004